Golden State Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$24.1K	Hold	183	–	–	﹤0.01%	872
2025 Q4	$26K	Hold	183	–	–	﹤0.01%	867
2025 Q3	$25.7K	Buy	183 +100	+120%	+$13.6K	﹤0.01%	854
2025 Q2	$10.4K	Sell	83 -100	-55%	-$11.5K	﹤0.01%	1068
2025 Q1	$20.2K	Hold	183	–	–	﹤0.01%	795
2024 Q4	$25K	Buy	+183	New	+$22.6K	﹤0.01%	714
2020 Q2	–	Sell	-54	Closed	-$5K	–	646
2020 Q1	$5K	Buy	+54	New	+$5.29K	﹤0.01%	746
2019 Q4	–	Sell	-54	Closed	-$5K	–	619
2019 Q3	$5K	Sell	54 -946	-95%	-$88.4K	﹤0.01%	863
2019 Q2	$84K	Buy	1,000 +500	+100%	+$41.1K	0.03%	355
2019 Q1	$44K	Buy	+500	New	+$41.8K	0.01%	476